• Explore /
  • Poster
  • / A phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair–proficient (MMR-P) recurrent or persistent endometrial cancer (EC).

A phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair–proficient (MMR-P) recurrent or persistent endometrial cancer (EC).

Abstract Poster

Authors

Elizabeth Lee

Elizabeth Katherine Lee

Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Elizabeth Katherine Lee , Niya Xiong , SuChun Cheng , Madeline Polak , Carolyn N. Krasner , Susana M. Campos , Alexi A. Wright , Joyce F. Liu , Meghan Shea , Oladapo O. Yeku , Cesar Martin Castro , Rebecca L Porter , Elizabeth Stover , Sara Bouberhan , John William Moroney , Richard T. Penson , Gini F. Fleming , Ursula A. Matulonis , Panagiotis A. Konstantinopoulos

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Uterine Cancer

Clinical Trial Registration Number

NCT02912572

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS5628)

DOI

10.1200/JCO.2023.41.16_suppl.TPS5628

Abstract #

TPS5628

Poster Bd #

315a

Abstract Disclosures

Similar Posters

First Author: Elizabeth Katherine Lee

First Author: Renata Ferrarotto

First Author: Ignace Vergote

First Author: Evelyn Cantillo